Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Innovative Research Reagents for Inflammation & Immune Responses
Toggle Nav
New Products Archive |
|
Latest Product Highlights ArchiveGDF15–GFRAL Axis as Promising Target for Multiple Sclerosis
|
News & Press ReleasesNEW findings position GDF15 as a crucial neuroimmune mediator and the GDF15–GFRAL axis as promising target for MS. Recently, the lab of Prof. Manuel A. Friese (University Medical Center Hamburg, Germany) reported in the journal Nature Immunology the crucial role of GDF15 in modulating immune responses in multiple sclerosis. Abcalis and AdipoGen Life Sciences Partner on Distributing Animal-free Recombinant Monoclonal and Multiclonal Antibodies on the Life Science Research Market |
Collaborating with |
|


























